10.71
전일 마감가:
$10.86
열려 있는:
$10.8
하루 거래량:
59,982
Relative Volume:
0.19
시가총액:
$548.95M
수익:
-
순이익/손실:
$-83.74M
주가수익비율:
-6.6522
EPS:
-1.61
순현금흐름:
$-64.98M
1주 성능:
+3.84%
1개월 성능:
+38.73%
6개월 성능:
-35.93%
1년 성능:
-39.85%
Tyra Biosciences Inc Stock (TYRA) Company Profile
명칭
Tyra Biosciences Inc
전화
(619) 728-4760
주소
2656 STATE STREET, CARLSBAD
TYRA을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
TYRA
Tyra Biosciences Inc
|
10.71 | 548.95M | 0 | -83.74M | -64.98M | -1.61 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
502.48 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
606.18 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ARGX
Argen X Se Adr
|
656.33 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
269.92 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
253.72 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-01-07 | 개시 | UBS | Buy |
2024-10-18 | 업그레이드 | BofA Securities | Neutral → Buy |
2024-08-15 | 개시 | Piper Sandler | Overweight |
2023-12-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
2023-06-30 | 개시 | Wedbush | Outperform |
2023-02-03 | 개시 | Oppenheimer | Outperform |
2022-06-23 | 개시 | H.C. Wainwright | Buy |
2022-03-08 | 업그레이드 | Jefferies | Hold → Buy |
2021-11-08 | 다운그레이드 | Jefferies | Buy → Hold |
2021-10-11 | 개시 | BofA Securities | Buy |
2021-10-11 | 개시 | Cowen | Outperform |
2021-10-11 | 개시 | Jefferies | Buy |
모두보기
Tyra Biosciences Inc 주식(TYRA)의 최신 뉴스
Tyra Biosciences (TYRA) to Release Earnings on Thursday - Defense World
Tyra Biosciences, Inc. (NASDAQ:TYRA) Shares Sold by JPMorgan Chase & Co. - Defense World
Russell Investments Group Ltd. Acquires 10,447 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Geode Capital Management LLC Has $7.20 Million Stock Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Tyra Biosciences Inc [TYRA] Records 50-Day SMA of $10.39 - knoxdaily.com
Should investors be concerned about Tyra Biosciences Inc (TYRA)? - uspostnews.com
Northrop Grumman Posts Downbeat Results, Joins Halliburton And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Why Calix Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket - Benzinga
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives $30.83 Average PT from Brokerages - Defense World
(TYRA) Investment Analysis and Advice - news.stocktradersdaily.com
Vanguard Group Inc. Sells 37,643 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Wellington Management Group LLP Has $1.32 Million Stock Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
American Century Companies Inc. Sells 20,857 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
KLP Kapitalforvaltning AS Buys New Stake in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
TYRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Tyra Biosciences Inc and Encourages Investors to Contact the Firm! - ACCESS Newswire
Advanced Urothelial Carcinoma Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - Barchart.com
Raymond James Financial Inc. Invests $761,000 in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
HC Wainwright Predicts Reduced Earnings for Tyra Biosciences - Defense World
Tyra Biosciences stock hits 52-week low at $8.14 - Investing.com Australia
Tyra Biosciences stock hits 52-week low at $8.14 By Investing.com - Investing.com South Africa
(TYRA) Technical Data - news.stocktradersdaily.com
HC Wainwright Reiterates “Buy” Rating for Tyra Biosciences (NASDAQ:TYRA) - The AM Reporter
Tyra Biosciences (NASDAQ:TYRA) Given Buy Rating at HC Wainwright - Defense World
H.C. Wainwright maintains $30 target on Tyra Biosciences stock By Investing.com - Investing.com Canada
Tyra Biosciences, Inc. (NASDAQ:TYRA) Shares Sold by Swiss National Bank - Defense World
What is Wedbush’s Estimate for TYRA FY2029 Earnings? - Defense World
Tyra Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights - Citizen Tribune
Wedbush Reiterates “Outperform” Rating for Tyra Biosciences (NASDAQ:TYRA) - Defense World
Companies Like Tyra Biosciences (NASDAQ:TYRA) Are In A Position To Invest In Growth - Yahoo Finance
Charles Schwab Investment Management Inc. Trims Stock Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Tyra Biosciences (NASDAQ:TYRA) Shares Gap Up After Better-Than-Expected Earnings - Defense World
Tyra Biosciences Advances Precision Medicine Pipeline - TipRanks
Tyra Biosciences, Inc. (NASDAQ:TYRA) Shares Bought by Bank of New York Mellon Corp - Defense World
Tyra Biosciences stock hits 52-week low at $9.9 amid market challenges By Investing.com - Investing.com South Africa
Tyra Biosciences stock hits 52-week low at $9.9 amid market challenges - Investing.com
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives $30.50 Consensus Target Price from Analysts - Defense World
Trend Tracker for (TYRA) - news.stocktradersdaily.com
Victory Capital Management Inc. Purchases 26,560 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Tyra Biosciences to Present at Oppenheimer's 34th Annual Healthc - GuruFocus.com
US Bancorp DE Purchases Shares of 3,612 Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Incyte, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga India
Why Precision BioSciences Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - NewsBreak: Local News & Alerts
Tyra Biosciences (NASDAQ:TYRA) Sees Large Volume Increase – Should You Buy? - Defense World
Tyra Biosciences Inc expected to post a loss of 48 cents a shareEarnings Preview - TradingView
(TYRA) On The My Stocks Page - Stock Traders Daily
Tyra Biosciences (TYRA) Expected to Announce Quarterly Earnings on Tuesday - Defense World
Tyra Biosciences stock hits 52-week low at $10.62 amid market challenges - Investing.com Australia
Tyra Biosciences stock hits 52-week low at $10.62 amid market challenges By Investing.com - Investing.com South Africa
Tyra Biosciences Inc (TYRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):